Sub menu

 
 

Consultation on the new Therapeutic Goods Order 106 - Data matrix codes and serialisation of medicines

Consultation period:
-

While the consultation is open you can make a submission at our TGA consultation hub.

We review the submissions carefully. After that the submissions and our decision will be available on the same page at the TGA consultation hub.

Overview

The Therapeutic Goods Administration (TGA) is seeking feedback on proposed requirements for serialisation and the use of data matrix codes on the labels of certain medicines in the Australian supply chain.

To make sure the standard is clear, meaningful and fit for purpose. We are seeking feedback on its suitability and potential impacts.  

Therapeutic Goods (Medicines—Standard for Serialisation and Data Matrix Codes) (TGO 106) Order 2020

Guidance for TGO 106 Medicines—Standard for Serialisation and Data Matrix Codes

Consultation paper

This consultation paper gives further details about data matrix codes and the standard.

Consultation paper - Data matrix codes and serialisation of medicines

All current TGA consultations can be found at the TGA consultation hub.

Topics

This webpage on the TGA website was printed on 21 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/consultation/consultation-new-therapeutic-goods-order-106-data-matrix-codes-and-serialisation-medicines

Help us improve the Therapeutic Goods Administration site